• Uncategorized

The Ebola Virus

TheEbola Virus

TheEbola Virus is one of the fatal illnesses experienced by humans.Ebola outbreaks pose a threat to lives with survival rates recordedas low as 10%. Initial detection of the infection occurred in 1976 insimultaneous diagnosis in Sudan and the Congo. The name Ebolaoriginates from River Ebola in the Democratic Republic of Congo. Mostof the outbreaks begun in the western African regions and has nowspread to numerous regions across the globe. However, as at mid-2012,no cases were reported in Asian Pacific areas. Global travelscontribute to the proliferation of the disease. The attacks commonlyoccur in marginalized areas usually adjacent to tropical rainforests.The virus originates from wild animals and transmits from human tohuman (Kollipara, Reisz &amp Reisz, 2015).

EbolaVirus Disease, identified as EVD is highly infectious. Symptoms mayappear within 48hours upon contraction but may prolong for up to 21days depending on the immunity of the victim Common symptoms includemuscles pains, fever, diarrhea and abnormal bleeding. People aroundthe world abhor the virus due to high death rate about other viralhemorrhagic fevers. The illness lacks conventional treatments andrelies on supportive therapy to contain extreme conditions such asprofuse bleeding (Sarkar, Singh &amp Ratho, 2015).

Thereare many arguments and misconceptions alike revolving around EVD.Most of the discussions critique infection methods of the disease.Current scientific evidence shows that the illness is neither air orwaterborne. It cannot also pass from one person to another by sharingmeals contrary to popular myths. EVD is only contracted throughexchange of blood and other bodily fluids with an infected person.Such conditions include contact with contaminated objects such asneedles. However, a victim cannot transmit the virus in the initialphase of the infection with no visible symptoms. Individuals who liveclosest to infected persons stand the highest chance of infection dueto a higher possibility of exchanging bodily fluids. Health works andfamily members stand the greatest chance of infection due to regularcontacts with infected persons (The Team, 2014).

Timelyscreening helps to increase the likelihood of survival. However, it’snot always possible to confirm the symptoms of EVD. Often, othersdiseases are mistaken for Ebola due to conflicting symptoms. Whenpresented with such cases, health professionals use variousmechanisms to account for possibilities of infections. A keyconsideration involves familiarizing with the victim`s activities forthe past 21 days in an area suspected to contain the virus. Also,doctors need to consider if the individual gained contact with aninfected person. There are certain scenarios where EVD is diagnoseddirectly mainly when a high fever is detected. If body temperaturerises to 38 degrees within 24 hours the, there is a possibility thatthe victim contracted the virus. Alternatively, if the suspectedperson admits close contact with a contaminated object, EVD isdiagnosed (Laupland, &amp Valiquette, 2014).

TheWorld Health Organization (WHO) discourages family members andfriends for taking upon themselves to care for Ebola patients. Suchactions only expose more people to the risk of infection with thedeadly virus. WHO recommends immediate medical attention andisolation to avoid exposure to the disease. Many nations havedeveloped protocols to fight the infection. Citizens are advised tofollow such regulations to help in containing the disease. Manyorganizations around the world have come together to create globalawareness about EVD. Most health protocols consider isolation as thebest reaction mechanism. Avoiding multiple infections is one of thebest ways to contain the virus in the long run. The role of healthagencies includes sensitizing individual in Ebola prone areas on howto approach future possibilities (Kollipara, Reisz &amp Reisz,2015).

Thereare no authentic treatments to Ebola. However, the victims of thevirus require specialized care and attention. They need constanthydration occasioned by a loss of water through diarrhea and loss ofblood. Prevention remains the principal mechanism to contain theillness and begins with raising awareness on the fatality of thevirus. It also involves undertaking relevant protective measure toreduce the mortality rates associated with EVD infections. Healthprofessional require are equally threatened by EVD and must be on thelookout. Proper sterilization should take place In the healthcenters to safeguard the patients and the health workers alike.Hospitals also need to administer standard precautions since EVDsymptoms are not identifiable in the initial phase of infection(Dixon &amp Schafer, 2014).

TheEbola Virus has many social implications. An outbreak of EVD createsdisharmony in the affected communities. Loss of loved ones causesagony to families because the deaths are usually slow and painful. Itcan lead to loss of talents and individuals with communalattributions such as leaders and team players. However, communitiesshould unite to fight the virus. They also require the shedding ofall misconceptions about the virus and considering the scientificapproaches. There are various ways in which the society cancontribute to reducing the spread of EVD. For instance, they shouldproperly bury Ebola victims to shield off a possible future spread ofthe virus. They should ensure proper cooking of meals especiallyanimal products with the possibility of contamination. At home level,routine cleaning can help inactivate EVD (Sarkar, Singh &amp Ratho,2015).

References

Dixon,M. G., &amp Schafer, I. J. (2014). Ebolaviral disease outbreak—WestAfrica, 2014. MMWR Morb Mortal Wkly Rep, 63(25), 548-51.

Kollipara,R., Reisz, G., &amp Reisz, C. (2015). Controlof the rove beetle in rapidly deployed Ebola treatment units (ETUs)is necessary for worker safety.JAAD case reports 1(6), 406.

Laupland,K. B., &amp Valiquette, L. (2014). Ebolavirus disease.The Canadian Journal of Infectious Diseases &amp MedicalMicrobiology, 25(3), 128.

Sarkar,S., Singh, M. P., &amp Ratho, R. K. (2015). Driedblood spot for Ebola testing in developing countries.The Lancet Infectious Diseases, 15(9), 1005.

Theteam, W. E. R. (2014). Ebolavirus disease in West Africa—thefirst nine months of the epidemic and forward projections. N Engl JMed, 2014(371), 1481-1495.